A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index.
Zell JA, McLaren CE, Morgan TR, Lawson MJ, Rezk S, Albers CG, Chen WP, Carmichael JC, Chung J, Richmond E, Rodriguez LM, Szabo E, Ford LG, Pollak MN, Meyskens FL.
Zell JA, et al. Among authors: mclaren ce.
Cancer Prev Res (Phila). 2020 Feb;13(2):203-212. doi: 10.1158/1940-6207.CAPR-18-0262. Epub 2019 Dec 9.
Cancer Prev Res (Phila). 2020.
PMID: 31818851
Free PMC article.
Clinical Trial.